Clinical Trials Logo

Optical Coherence Tomography clinical trials

View clinical trials related to Optical Coherence Tomography.

Filter by:

NCT ID: NCT03593928 Recruiting - Clinical trials for Myocardial Infarction

Optical Coherence Tomography Examination in Acute Myocardial Infarction

OCTAMI
Start date: March 29, 2017
Phase:
Study type: Observational

Different plaque morphology may have an important effect on the prognosis of acute myocardial infarction (AMI), as recent studies show that patients with plaque rupture have a significantly higher risk of cardiac events compared with those with plaque erosion. The primary purpose of this study is to find risk factors and biomarkers for different culprit lesion morphology to perform accurate risk stratification and determine an appropriate treatment strategy for patients with AMI.

NCT ID: NCT03574636 Recruiting - Clinical trials for Optical Coherence Tomography

OCT vs IVUS vs QCA to Guide Moderate-to-severe Calcified Lesion Stent Implantation

Start date: October 18, 2019
Phase: N/A
Study type: Interventional

This study is a prospective, multi-center, randomized controlled clinical trial, aims to assess the safety and effectiveness of Optical Coherence Tomography or Intravascular Ultrasound or Quantitative Coronary Analysis to guide Firehawk stent implantation , and compared the treatment of moderate-to-severe calcified lesion in coronary artery.

NCT ID: NCT03474432 Recruiting - Clinical trials for Percutaneous Coronary Intervention

SOLEMN Study - Synergy Optical Coherence Tomography in Left Main PCI

SOLEMN
Start date: June 15, 2018
Phase: N/A
Study type: Interventional

BACKGROUD: Percutaneous coronary intervention (PCI) is increasingly used to treat unprotected left main coronary artery stenosis. Protected LM PCI is considered standard of care in most centers. OCT allows for precise determination of stent placement, stent expansion and apposition. The pattern of vessel healing can be very precisely studied if immediate post-stent implantation OCT/IVUS data is compared to the 6-month post-PCI interval. While OCT cannot be optimally used for ostial lesion imaging, IVUS can be used to image ostial lesions/stent placement. Optimal and consistent vessel healing is particularly important in LM PCI where stent thrombosis is a potential complication with serious adverse outcome. HYPOTHESIS: Due to the absorption of the polymer of the Boston Scientific Synergy Stent over time, early strut coverage patterns and timeline may be different than previously observed in DES and BMS stents in LM PCI. Late acquired stent malapposition (LASM) is expected to differ from previous observations with traditional DES/BMS. Stent coverage in LM PCI will be studied with OCT or IVUS at six and 12 months and compared to OCT or IVUS at the time of stent implantation. OCT/IVUS data will be analyzed in a core lab (CRF) and correlated with clinical outcomes at 6 and 12 months.

NCT ID: NCT02966262 Recruiting - Clinical trials for Coronary Artery Disease

Korea University Anam Hospital Optical Coherence Tomography Registry

Start date: April 2016
Phase: N/A
Study type: Observational [Patient Registry]

All comer registry who had undergone intravascular optical coherence tomography during and/or after coronary intervention.